E Sharma - Guys and St Thomas’ NHS Foundation Trust, Gastroenterology, London, United Kingdom

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 10 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

How achievable are the STRIDE-II treatment targets in real-world practise and do they affect outcome

E. Routledge, S. Meade,E. Sharma,S. Zeki,S. Ray,S. Anderson,J. Sanderson,J. Mawdsley,M. Samaan

Journal of Crohn's and Colitis（2022）

引用0浏览0引用

Longer-term tofacitinib effectiveness for the treatment of ulcerative colitis: Two-year outcomes from a UK observational cohort study

S. Honap,E. Sharma,S. Ray,J. Mawdsley,S. Anderson,M. Samaan,P. Pavlidis,P. Irving

Journal of Crohn's and Colitis（2022）

引用0浏览0引用

Underutilisation of novel and alternative oral iron preparations may incur unnecessary cost in iron deficiency anaemia treatment in inflammatory bowel disease

E. Sharma, J. Kotecha, A. Akintimehin,S. Ray, S. H. Anderson,J. Mawdsley,P. M. Irving,M. A. Samaan

Journal of Crohn's and Colitis（2022）

引用0浏览0引用

Safety analysis of tofacitinib in ulcerative colitis: Real-world outcomes from a three-year UK observational cohort study

S. Honap,E. Sharma,S. Ray,J. Mawdsley,S. Anderson,M. Samaan,P. Pavlidis,P. Irving

Journal of Crohn's and Colitis（2022）

引用0浏览0引用

Vedolizumab Associated quality of Life and inflammatory bowel disease control Upon Entering a subcutaneous switching program (VALUE) - Results from a multi-centre UK study

S. Lim,B. Gros Alcade, A. Lehmann,J. Lindsay,D. Gaya, L. Caulfield,A. Dhar, S. Ritchie, J. Limdi,J. Taylor, T. Raine,K. Balendran,

Journal of Crohn's and Colitis（2022）

引用2浏览0引用

Risankizumab in Inflammatory Bowel Disease: Real World Experience from a Pre-Approval Access Program

P. Dawson,E. Sharma, R. J. Dart,S. Lim, S. H. Anderson, S. Ray,J. Mawdsley,P. M. Irving,M. A. Samaan

Journal of Crohn's and Colitisno. Supplement_1 (2022): I355-I355

引用1浏览0引用

P411 Stable pharmacokinetics and biochemical markers of inflammatory bowel disease activity: Results from a real-world adalimumab biosimilar switching program

A C Moore, D Russell,R Dart, S Dias, S Ghuman,B Petri,E Sharma, S Ray, S Anderson,J Mawdsley,P M Irving,M A Samaan

Journal of Crohn's and Colitisno. Supplement_1 (2022): I401-I402

引用0浏览0引用

Biologic longevity: Withdrawal of drugs due to remission is rare in clinical practice

E. Sharma,G. Cunningham,P. Dawson, F. D'Errico, S. Honap,S. Lim,R. Luber, S. Meade,P. Pavlidis,R. Reynolds,P. Irving

Journal of Crohns & Colitisno. SUPnan (2020): S320-S321

引用0浏览0引用

Tofacitinib in ulcerative colitis: Early 'real-world' experience from four UK tertiary centres

D. Chee, S. Honap,T. P. Chapman,A. J. Kent,M. Patel,B. Hayee,P. Dubois, L. Medcalf,E. Sharma, Y. Begum,S. Ray,J. Kennedy,

JOURNAL OF CROHNS & COLITIS（2020）

引用0浏览0引用

The effects of covid19 on IBD prescribing and service provision

S. Meade,E. Sharma, F. D'Errico,P. Pavlidis, R. Luber, S. S. Zeki, A. Caracostea, K. Hill, D. O'Hanlon, A. Duff, S. Tripoli, A. Stanton,

United European gastroenterology journal（2020）

引用0浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn